Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

519 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
HER-2-targeted boron neutron capture therapy using an antibody-conjugated boron nitride nanotube/β-1,3-glucan complex.
Yamana K, Kawasaki R, Kondo K, Hirano H, Kawamura S, Sanada Y, Bando K, Tabata A, Azuma H, Takata T, Sakurai Y, Tanaka H, Kodama T, Kawamoto S, Nagasaki T, Ikeda A. Yamana K, et al. Among authors: sanada y. Nanoscale Adv. 2023 Jun 1;5(15):3857-3861. doi: 10.1039/d3na00028a. eCollection 2023 Jul 25. Nanoscale Adv. 2023. PMID: 37496630 Free PMC article.
Effect of oxygen pressure during incubation with a (10)B-carrier on (10)B uptake capacity of cultured p53 wild-type and mutated tumor cells: dependency on p53 status of tumor cells and types of (10)B-carriers.
Masunaga S, Tatebe H, Nishimura Y, Tano K, Sanada Y, Moriwaki T, Sakurai Y, Tanaka H, Suzuki M, Kondo N, Maruhashi A, Ono K. Masunaga S, et al. Among authors: sanada y. Int J Radiat Biol. 2016;92(4):187-94. doi: 10.3109/09553002.2016.1137104. Epub 2016 Feb 18. Int J Radiat Biol. 2016. PMID: 26887694
Comparison of the pharmacokinetics between L-BPA and L-FBPA using the same administration dose and protocol: a validation study for the theranostic approach using [18F]-L-FBPA positron emission tomography in boron neutron capture therapy.
Watanabe T, Hattori Y, Ohta Y, Ishimura M, Nakagawa Y, Sanada Y, Tanaka H, Fukutani S, Masunaga SI, Hiraoka M, Ono K, Suzuki M, Kirihata M. Watanabe T, et al. Among authors: sanada y. BMC Cancer. 2016 Nov 8;16(1):859. doi: 10.1186/s12885-016-2913-x. BMC Cancer. 2016. PMID: 27821116 Free PMC article.
Significance of Fractionated Administration of Thalidomide Combined With γ-Ray Irradiation in Terms of Local Tumor Response and Lung Metastasis.
Masunaga SI, Sanada Y, Moriwaki T, Tano K, Sakurai Y, Tanaka H, Suzuki M, Kondo N, Narabayashi M, Watanabe T, Nakagawa Y, Maruhashi A, Ono K. Masunaga SI, et al. Among authors: sanada y. World J Oncol. 2014 Aug;5(4):155-165. doi: 10.14740/wjon855w. Epub 2014 Aug 25. World J Oncol. 2014. PMID: 29147396 Free PMC article.
Usefulness of combination with both continuous administration of hypoxic cytotoxin and mild temperature hyperthermia in boron neutron capture therapy in terms of local tumor response and lung metastatic potential.
Masunaga SI, Sakurai Y, Tanaka H, Takata T, Suzuki M, Sanada Y, Tano K, Maruhashi A, Ono K. Masunaga SI, et al. Among authors: sanada y. Int J Radiat Biol. 2019 Dec;95(12):1708-1717. doi: 10.1080/09553002.2019.1666214. Epub 2019 Sep 23. Int J Radiat Biol. 2019. PMID: 31545117
An attempt to improve the therapeutic effect of boron neutron capture therapy using commonly employed 10B-carriers based on analytical studies on the correlation among quiescent tumor cell characteristics, tumor heterogeneity and cancer stemness.
Masunaga SI, Sanada Y, Tano K, Sakurai Y, Tanaka H, Takata T, Suzuki M, Ono K. Masunaga SI, et al. Among authors: sanada y. J Radiat Res. 2020 Nov 16;61(6):876-885. doi: 10.1093/jrr/rraa048. J Radiat Res. 2020. PMID: 32601693 Free PMC article.
519 results